Skip to main navigation Skip to search Skip to main content

A new bioactive dermal substitute for wound healing and skin regeneration

Research output: Contribution to conference › Abstract › peer-review

9 Downloads

Abstract

Aim: Rabbit skin is an abundant agri-food by-product with interesting properties to be up-cycled into a xenogeneic dermal substrate for skin and regeneration. When decellularized, rabbit dermis preserves collagen–elastin components that can guide cell behavior. However, decellularization conditions can also influence the preservation of tissue architecture and may introduce immunogenic triggers such as damage-associated molecular patterns (DAMPs). This work aimed to develop low-immunogenicity decellularized dermal matrices (dDMs) using rabbit skin as by- product. Method: dDMs were generated using optimized chemical decellularization protocols and evaluated for structural and biochemical integrity using SEM, tensile testing, FTIR, proteomics, and DNA, GAGs, collagen, and elastin quantification. Immunogenicity was assessed throughendotoxin analysis and by exposing human peripheral blood mononuclear cells (PBMCs) to the matrices to measure complement activation, ROS, apoptosis, activation markers, and cytokine release. The ability of dDMs to support human dermal fibroblasts (hDFs) and keratinocytes (HaCaTs) was examined over 14 days using Alamar Blue, BrdU, SEM, and DAPI/phalloidin staining. Results/Discussion: dRDMs preserved native collagen–elastin architecture, and GAG levels were comparable to human dermis. Residual DNA confirmed effective decellularization. No significant immune activation occurred: ROS and apoptosis were absent, and PBMC activation matched controls with only mild monocyte and B-cell responses. Cytokine release indicated modest inflammatory signaling induction. Interestingly, matrices with lower DNA content triggered stronger immune responses, suggesting biocompatibility is influenced more by processing-related factors (detergent residues or DAMPs) than by DNA levels. hDF and HaCaT adhesion, viability, and proliferation were maintained for 14 days. Conclusion: dRDMs showed favorable structural, biochemical, and immunological profiles and supported dermo-epidermal cell growth, demonstrating potential as bioactive dermal substitutes for skin regeneration.
Original languageEnglish
Number of pages2
Publication statusPublished - May 2026
Event36th Conference of the European Wound Management Association - DEWU Deutscher Wundkongress, Bremen, Germany
Duration: 6 May 2026 → 8 May 2026

Conference

Conference36th Conference of the European Wound Management Association
Abbreviated titleEWMA 2026
Country/TerritoryGermany
CityBremen
Period6/05/26 → 8/05/26

Fingerprint

Dive into the research topics of 'A new bioactive dermal substitute for wound healing and skin regeneration'. Together they form a unique fingerprint.

Cite this